home / stock / iccm / iccm news


ICCM News and Press, IceCure Medical Ltd. From 12/01/23

Stock Information

Company Name: IceCure Medical Ltd.
Stock Symbol: ICCM
Market: NASDAQ
Website: icecure-medical.com

Menu

ICCM ICCM Quote ICCM Short ICCM News ICCM Articles ICCM Message Board
Get ICCM Alerts

News, Short Squeeze, Breakout and More Instantly...

ICCM - SEEL, AMPE and MOR among pre-market losers

2023-12-01 08:25:56 ET Losers: Smart for Life ( SMFL ) -38% announces exercise of warrants for $1.5 Million gross proceeds . Ampio Pharmaceuticals ( AMPE ) -34% . Incannex Healthcare ( IXHL ) -34% . Vivos Therapeutics ( VVOS ) -14% . ...

ICCM - FRO, DNMR and RDHL among pre-market losers

2023-11-30 08:40:55 ET Losers: Vivos Therapeutics ( VVOS ) -34% . Redhill Biopharma Ltd. ( RDHL ) -26% . Yoshiharu Global Co ( YOSH ) -25% . XORTX Therapeutics XRTX -18% announces $3.70M US ATM offering . Pure Storage PSTG -15% after...

ICCM - Redhill Biopharma, BioVie among healthcare movers

2023-11-29 10:00:03 ET More on Health Care Select Sector SPDR Ideal Pairs Trade Into 2024: Health Vs. Hype: Capitalizing On A Therapeutic Turn And A Tech Tumble Health Care Select Sector Fund ETF: Riding The Healthcare Boom Stocks to watch in the Health Care sector a...

ICCM - ESGL, HNRA and SMX among pre-market losers

2023-11-29 08:23:49 ET Losers: Seelos Therapeutics ( SEEL ) -43% on pricing of $5.55 million stock offering . Leslies ( LESL ) -20% after Q4 earnings release . Farfetch Ltd ( FTCH ) -16% . ESGL Holdings Ltd ( ESGL ) -15% . Petco ...

ICCM - IceCure's ProSense® Deepens Regulatory Approval in India

IceCure's ProSense® Deepens Regulatory Approval in India PR Newswire ProSense® is already marketed and sold in India based on previous regulatory requirements and now has been re-classified due to new regulations Breast cancer cryoablation is alre...

ICCM - 24/7 Market News Lunch Break 28 Nov 2023

2023-11-28 12:33:30 ET DENVER, Colo., Nov. 28, 2023 ( www.247marketnews.com )- The following companies published announcements or are trading higher on higher-than-usual midday volume; Icecure Medical Ltd (NASDAQ: ICCM), Avidity Biosciences Inc (NASDAQ: RNA), ESGL Holdings Ltd (NASDAQ: ...

ICCM - IceCure shares rally 53% on ProSense kidney cancer study

2023-11-28 09:39:12 ET More on IceCure Medical IceCure Medical Ltd (ICCM) Q3 2023 Earnings Call Transcript IceCure stock climbs 10% amid FDA appeal, earnings report IceCure Medical 9M GAAP EPS of -$0.26, revenue of $2M Seeking Alpha’s Quant Rating on I...

ICCM - IceCure System Successfully Treated Kidney Cancer Tumor with 92% Disease-Free Survival Rate and 100% Secondary Local Control Rate

IceCure System Successfully Treated Kidney Cancer Tumor with 92% Disease-Free Survival Rate and 100% Secondary Local Control Rate PR Newswire Independent study concluded: - IceCure system offers significant advantage in ability to re-treat tumors that are initial...

ICCM - IceCure Medical Ltd (ICCM) Q3 2023 Earnings Call Transcript

2023-11-15 14:56:03 ET IceCure Medical Ltd. (ICCM) Q3 2023 Earnings Conference Call November 15, 2023, 10:00 AM ET Company Participants Michael Polyviou - EVC Group, Investor Relations Eyal Shamir - Chief Executive Officer Ronen Tsimerman - Chief Financial Office...

ICCM - IceCure stock climbs 10% amid FDA appeal, earnings report

2023-11-15 11:05:05 ET More on IceCure Medical IceCure Medical 9M GAAP EPS of -$0.26, revenue of $2M IceCure stock soars 85% in pre-market trading on positive study results Seeking Alpha’s Quant Rating on IceCure Medical Historical earnings data for Ic...

Previous 10 Next 10